PRB1-3 Inhibitors
PRB1-3 inhibitors are a class of chemical compounds designed to target and inhibit the function of PRB1-3, which refers to members of the PRB (Proline-Rich Protein B) family, specifically PRB1, PRB2, and PRB3. These proteins are primarily found in salivary glands, where they play key roles in the secretion and function of saliva. PRB1-3 proteins belong to the proline-rich protein family, which is involved in various biological processes such as the maintenance of oral health, lubrication, and the formation of the protective film in the oral cavity. These proteins are known to interact with other salivary components and help modulate the mineral balance in the oral cavity, contributing to tooth enamel maintenance and protection against environmental factors. Inhibition of PRB1-3 allows researchers to study the molecular mechanisms underlying these functions, providing a better understanding of how these proteins contribute to oral physiology.
In research settings, PRB1-3 inhibitors are used to investigate the regulatory roles of these proteins in oral and salivary gland function. By blocking the activity of PRB1-3 proteins, scientists can explore how these inhibitors affect processes such as saliva composition, mineral homeostasis, and the protective functions that saliva provides. This inhibition allows for the analysis of how PRB1-3 proteins contribute to the overall maintenance of the oral environment, including their potential role in interactions with other salivary proteins and enzymes. Additionally, PRB1-3 inhibitors provide insight into the downstream effects on oral health, offering valuable data on how disruptions in salivary protein function can lead to imbalances in oral hygiene and physiology. Through these studies, the use of PRB1-3 inhibitors enhances our understanding of the complex molecular systems that regulate the function of saliva and its crucial role in maintaining oral health and integrity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Benzamidine is a competitive inhibitor of serine proteases like trypsin, which PRB1 is a member of. It binds to the active site of PRB1, preventing substrate access and thereby inhibiting its protease activity. | ||||||
Phenylmethylsulfonyl Fluoride | 329-98-6 | sc-3597 sc-3597A | 1 g 100 g | $50.00 $697.00 | 92 | |
PMSF irreversibly inhibits serine proteases by sulfonylating the hydroxyl group in the active site serine of PRB1, which is essential for its proteolytic activity. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a small protein that acts as a competitive inhibitor by binding tightly to the active sites of serine proteases, including PRB1, inhibiting their enzymatic activity. | ||||||
Chymostatin | 9076-44-2 | sc-202541 sc-202541A sc-202541B sc-202541C sc-202541D | 5 mg 10 mg 25 mg 50 mg 100 mg | $156.00 $260.00 $640.00 $1186.00 $2270.00 | 3 | |
Chymostatin is a competitive inhibitor of chymotrypsin-like serine proteases. It inhibits PRB1 by binding to its active site, preventing substrate cleavage. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF is an irreversible inhibitor of serine proteases that reacts with the serine residue in the active site of PRB1, thereby inhibiting its protease activity. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a potent inhibitor of cysteine proteases; however, it can inhibit PRB1 by reacting with its active site cysteine, if present, or by modifying nearby amino acids influencing the active site conformation. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate mesilate is a synthetic protease inhibitor that inhibits serine proteases such as PRB1 by binding to the active site serine, thus preventing substrate access. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat mesilate is a broad-spectrum serine protease inhibitor that binds to PRB1 and inhibits its activity by blocking the active site. | ||||||